-
Location
-
C/O Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato, CA
-
Summary
-
The estimated net worth of Shalini Sharp is at least $6M dollars as of June 20, 2025. Shalini Sharp is the Director of BeiGene, Ltd. and owns shares of BeiGene, Ltd. (ONC) stock worth about $4.69M. Shalini Sharp is the Director of NEUROCRINE BIOSCIENCES INC and owns shares of NEUROCRINE BIOSCIENCES INC (NBIX) stock worth about $680K. Shalini Sharp is the Director of Organon & Co. and owns shares of Organon & Co. (OGN) stock worth about $633K.
-
Signature
-
/s/ Jeffrey Finer, Attorney-in-Fact